The Toronto Dominion Bank Has $21.20 Million Stake in Colgate-Palmolive Company (CL)

The Toronto Dominion Bank Has $21.20 Million Stake in Colgate-Palmolive Company (CL)

Other institutional investors have also recently added to or reduced their stakes in the company. Advantage Investment Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $104,000. North Star Investment Management Corp. increased its position in Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after buying an additional 67 shares in the last quarter. Security Asset Management acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $131,000. SRS Capital Advisors Inc. acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $132,000. Finally, Kistler Tiffany Companies LLC increased its position in Colgate-Palmolive by 8.8% in the first quarter. Kistler Tiffany Companies LLC now owns 2,035 shares of the company’s stock worth $149,000 after buying an additional 165 shares in the last quarter. Hedge funds and other institutional investors own 73.74% of the company’s stock.

Toronto Dominion Bank boosted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 40.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 289,470 shares of the company’s stock after buying an additional 83,119 shares during the period. Toronto Dominion Bank’s holdings in Colgate-Palmolive were worth $21,195,000 as of its most recent filing with the SEC.

Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.11% during trading on Wednesday, hitting $71.62. 3,059,714 shares of the stock were exchanged. The firm has a market capitalization of $63.09 billion, a price-to-earnings ratio of 26.61 and a beta of 0.80. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock’s 50 day moving average price is $73.87 and its 200 day moving average price is $72.62.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The business had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.70 earnings per share. On average, equities analysts predict that Colgate-Palmolive Company will post $2.90 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive’s payout ratio is currently 59.48%.

Several brokerages recently issued reports on CL. Citigroup Inc. restated a “neutral” rating and set a $76.00 price objective (up from $75.00) on shares of Colgate-Palmolive in a research report on Friday, April 7th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Thursday, May 25th. UBS AG reaffirmed a “neutral” rating and set a $78.00 target price (down from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Finally, BidaskClub cut shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $75.82.

In other news, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard J. Kogan sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $71.92, for a total transaction of $575,360.00. Following the sale, the director now directly owns 73,065 shares in the company, valued at approximately $5,254,834.80. The disclosure for this sale can be found here. Insiders sold a total of 112,040 shares of company stock valued at $8,116,989 over the last ninety days. 1.02% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Related posts

Leave a Comment